The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $118.99

Today's change+5.79 +5.11%
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $118.99

Today's change+5.79 +5.11%
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.

United Therapeutics Corp Hits New 20-day High

United Therapeutics Corp closed up sharply Thursday, rallying (U.S.)$5.79 or 5.11% to (U.S.)$118.99 and setting a new 20-day high. Over the last five days, shares have gained 5.83%, but are down 24.02% for the last year to date. Shares have underperformed the S&P 500 by 31.97% during the last year.

Key company metrics

  • Open(U.S.) $114.01
  • Previous close(U.S.) $113.20
  • High(U.S.) $119.92
  • Low(U.S.) $112.73
  • Bid / Ask-- / --
  • YTD % change-24.02%
  • Volume956,048
  • Average volume (10-day)505,834
  • Average volume (1-month)616,659
  • Average volume (3-month)688,770
  • 52-week range(U.S.) $97.52 to (U.S.) $172.39
  • Beta1.59
  • Trailing P/E6.58×
  • P/E 1 year forward7.97×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $18.10
Updated July 28 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue369405386347
Total other revenue--------
Total revenue369405386347
Gross profit368380379331
Total cost of revenue125716
Total operating expense5250-1175
Selling / general / administrative5149-17110
Research & development0761049
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income364155387172
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--0350--
Other--------
Income before tax364156737168
Income after tax23610546499
Income tax, total1285127269
Net income23610546499
Total adjustments to net income--------
Net income before extra. items23610546499
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23610546499
Inc. avail. to common incl. extra. items23610546499
Diluted net income23610546499
Dilution adjustment--------
Diluted weighted average shares49505052
Diluted EPS excluding extraordinary itemsvalue per share4.842.109.241.91
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share4.842.104.851.91